| 영문 | hemolytic disease of newborn | 한글 | 신생아용혈병 |
|---|---|---|---|
| 설명 | 신생아에서 적혈구가 비정상적으로 많이 파괴되는 병으로 태아적모구증(erythroblastosis fetalis)와 같은 뜻으로 쓰인다. 이것은 어머니에게서 생산된 신생아나 태아의 적혈구에 대한 항체가 태반을 건너와서 태아의 적혈구와 결합하여서 생기는 용혈성빈혈을 이르는 말. 즉 신생아나 태아의 적혈구의 항체가 어머니의 몸에서 생산이 되고 이것이 태반을 통해서 태아에게 넘어가서 태아의 적혈구와 결합을 하고 이 항체와 결합한 적혈구는 파괴가 되어서 빈혈이 생긴 것을 태아적모구증이라고 한다. 이것은 Rh 적모구증(Rh erythroblastosis)와 ABO 적모구증(ABO erythroblastosis)로 나눌 수가 있다. |
||
| 영문 | fetus | 한글 | 태아 |
|---|---|---|---|
| 설명 | 사람의 경우는 보통 임신 제2개월 말(8주) 이후를 태아라고 하며, 그 때까지는 배아라고 하여 구별하고 있다. 태아기에서는 동물의 경우와 외관상 거의 구별이 없고 임신 8주째가 되어야 비로소 뚜렷해진다. 태아기는 임신의 극히 초기이며 자칫하면 모르고 지나치기 쉬운데, 이 무렵에 심장을 비롯하여 중요한 기관이 생기므로, 모체의 바이러스 감염이나 약물복용(탈리도미드계 수면제) 외에 X선조사가 원인이 되어 태아병이 생기는 일이 있다. 태아의 순조로운 발육은 태동의 자각이나 태아 부분의 촉진 외에 태아 심음의 청취나 태아심전도-X선사진에 의하여 확인할 수 있다. 또 난막-태반-탯줄-양수는 태아부속물인데, 특히 태반은 태아에게 있어서 허파-창자-콩팥 등의 구실을 모체 대신 수행하는 중요한 기관이다. 또 태아는 법률상 상속이나 손해배상 청구 등의 이익이 발생한 경우에는 태어난 것으로 간주하여 다루게 됨으로써 보호를 받고 있다. |
||
| HBsAg/adr | hepatitis B surface antigen manifesting group-specific determinant a and subtype-specific determinan... |
|---|---|
| PULSES | physical condition, upper limb function, lower limb function, sensory component, excretory function,... |
| SR | sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat... |
| FDA | fluorescein diacetate; Food and Drug Administration; right frontoanterior [position of the fetus] |
| HN | head and neck; head nurse; hemagglutinin neuraminidase; hematemesis neonatorum; hemorrhage of newbor... |
| congenital epulis of newborn | A congenital benign nodular tumour of the alveolar ridge, of unknown histogenesis; histologically, it is composed of large cells with a granular cytoplasm similar to that of a granular cell tumour (myoblastoma). (05 Mar 2000) |
|---|---|
| postnatal pit of the newborn | It marks the site where the embryonic spinal cord attaches to the skin. Synonym: postnatal pit of the newborn. (05 Mar 2000) |
| haemolytic anaemia of newborn | <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells). Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia. (27 Sep 1997) |
| haemolytic disease of newborn | <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells). Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia. (27 Sep 1997) |
| haemolytic disease of the newborn | Abnormal breakup of red blood cells in the foetus or newborn. This is usually due to antibodies made by the mother directed against the baby's red cells. It is typically caused by rh incompatibility, that is differences between the mother and baby uinvolving the rh blood group. (12 Dec 1998) |
| haemorrhagic disease of newborn | A self-limited haemorrhagic disorder of the first days of life, caused by a deficiency of the vitamin k-dependent blood coagulation factors II, vii, ix, and x. (12 Dec 1998) |
| haemorrhagic disease of the newborn | A syndrome characterised by spontaneous internal or external bleeding accompanied by hypoprothrombinaemia, slightly decreased platelets, and markedly elevated bleeding and clotting times, usually occurring between the third and sixth days of life and effectively treated with vitamin K. (05 Mar 2000) |
| hyaline membrane disease of the newborn | A disease seen especially in premature neonates with respiratory distress; characterised postmortem by atelectasis and alveolar ducts lined by an eosinophilic membrane; also associated with reduced amounts of lung surfactant. Synonym: hyaline membrane syndrome, respiratory distress syndrome of the newborn. (05 Mar 2000) |
| spontaneous gangrene of newborn | Gangrene due to vascular occlusion of unknown cause, usually in marasmic or dehydrated infants. (05 Mar 2000) |
| newborn | neonatal, neonate |
| newborn jaundice | <paediatrics> A normal condition of elevated bilirubin in the bloodstream of a newborn. This occurs secondary to immaturity of liver cells (cannot effectively metabolise bilirubin) and the increased destruction of red blood cells (further releasing bilirubin into the bloodstream) that is normally seen in the newborn. The jaundice usually appears between the 2nd and 5th days of life and usually clears by 2 weeks. Other factors which can potentiate jaundice in the newborn include: sepsis, biliary atresia, Rhesus incompatibility, galactosaemia, cephalohaematoma, polycythaemia, G-6-P-D deficiency and congenital rubella, syphilis, toxoplasmosis or cytomegalovirus infection. (10 Jan 1998) |
| newborn screening | Tests of newborns to detect those at increased risk for disorders such as pku (phenylketonuria) and hypothyroidism. (12 Dec 1998) |
| subcutaneous fat necrosis of newborn | Indurated plaques and nodules appearing usually a few days or a few weeks after birth and usually resolving within a few months, characterised microscopically by birefringent needle-shaped crystals within necrotic fat cells; the condition remains localised, unlike sclerema neonatorum. (05 Mar 2000) |
| disease, haemolytic, of the newborn | Abnormal breakup of red blood cells in the foetus or newborn. (12 Dec 1998) |
| infant, newborn | An infant during the first month after birth. (12 Dec 1998) |